55 days to first decision for reviewed manuscripts only
40 days to first decision for all manuscripts
133 days from submission to acceptance
31 days from acceptance to publication

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports.
Although the primary focus is Alzheimer's disease, the scope encompasses translational research into other neurodegenerative diseases.

Research articles
Debates
Commentaries
Letters
Meeting reports
Reviews
Viewpoints

Editors-in-Chief

Todd E Golde, University of Florida, USA
Philip Scheltens, VU University Medical Center, Netherlands
Doug Galasko, University of California, San Diego, USA
Associate Editors
Michael Heneka, University Hospital Bonn, Germany
Seth Love, University of Bristol, UK
Rik Ossenkoppele, VU University Medical Center, Netherlands
Charlotte Teunissen, VU University Medical Center, Netherlands
Pieter Jelle Visser, VU University Medical Center, Netherlands
Editorial Board
Paul Aisen, University of Southern California, USA
Kevin Barnham, The University of Melborne, Australia
Randall Bateman, Washington University, USA
Sandra E. Black, University of Toronto, Canada
Kaj Blennow, Göteborg University, Sweden
Rachelle Doody, Hoffmann-La Roche, USA
Nick Fox, University College London, UK
Alison Goate, Mount Sinai Hospital, USA
Jurgen Goetz, University of Sydney, Australia
Neill R. Graff-Radford, Mayo Clinic, Jacksonville, USA
Suzanne Hendrix, Pentara Corporation, USA
Takeshi Iwatsubo, University of Tokyo, Japan
Jianping Jia, Xuan Wu Hospital of Beijing Capital Medical University, China
SangYun Kim, Seoul National University, Republic of Korea
Matthew Lambon Ralph, University of Manchester, UK
Giancarlo Logroscino, University of Bari, Italy
José Luis Molinuevo, Barcelonabeta Brain Research Center, Spain
Ralph A. Nixon, New York University, USA
Agneta Nordberg, Karolinska Institute, Sweden
Rik Ossenkoppele, VU University Medical Center, Netherlands
Stuart Pickering-Brown, Manchester University, UK
Gil Rabinovici, University of California, San Francisco, USA
Kenneth Rockwood, Dalhousie University, Canada
Charlotte Teunissen, VU University Medical Center, Netherlands 
Jinzhou Tian, Beijing University of Chinese Medicine, China
Victor L. Villemagne, The University of Melbourne, Australia
Pieter Jelle Visser, VU University Medical Center, Netherlands
Dominic Walsh, Brigham and Womens Hospital, USA
Donna M. Wilcock, University of Kentucky, USA
Bengt Winblad, Karolinska Institute, Sweden
Thomas Wisniewski, New York University, USA